| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10.1M | — | +5.6% |
| Cost of Revenue | $4.3M | — | +147.5% |
| Gross Profit | $5.8M | — | -25.8% |
| R&D Expense | $91.7M | — | +58.5% |
| SG&A Expense | $47.0M | — | +68.0% |
| Operating Income | -$133.0M | — | -70.4% |
| Pre-tax Income | -$122.1M | — | -56.2% |
| Income Tax | $216K | — | +120.4% |
| Net Income | -$122.3M | — | -56.2% |
| EPS (Basic) | -$0.53 | — | +73.2% |
| EPS (Diluted) | -$0.53 | — | +73.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.59B | -7.1% | +571.8% |
| Accounts Receivable | $6.4M | +11.9% | — |
| Current Assets | $1.62B | -6.8% | — |
| Total Assets | $2.01B | -4.4% | — |
| Current Liabilities | $75.9M | -0.7% | — |
| Long-term Debt | $177.6M | -4.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$95.4M | — | -63.7% |
| Capital Expenditures | $24.2M | — | +261.9% |
| Investing Cash Flow | -$24.2M | — | -286.8% |
| Financing Cash Flow | -$1.2M | — | -302.6% |
| Free Cash Flow | -$119.5M | — | -84.1% |
| — |
| Total Liabilities | $287.8M | -0.2% | — |
| Stockholders' Equity | $1.73B | -5.1% | +370.8% |